The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACER THERAPEUTICS INC | COM | 00444P108 | 3,572 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 4,816 | 919,000 | SH | SOLE | 919,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 3,744 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 547 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,817 | 87,500 | SH | SOLE | 87,500 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 7,927 | 63,500 | SH | SOLE | 63,500 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 3,074 | 167,500 | SH | SOLE | 167,500 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 4,635 | 314,000 | SH | SOLE | 314,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 14,974 | 760,500 | SH | SOLE | 760,500 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 204 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 10,603 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 2,574 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
CAS MED SYS INC | COM PAR | 124769209 | 12,790 | 5,263,508 | SH | SOLE | 5,263,508 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 231 | 41,667 | SH | SOLE | 41,667 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,872 | 517,500 | SH | SOLE | 517,500 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 8,625 | 636,500 | SH | SOLE | 636,500 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 4,817 | 328,825 | SH | SOLE | 328,825 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 5,827 | 61,000 | SH | SOLE | 61,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 1,300 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 9,605 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 10,756 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 27,999 | 2,944,201 | SH | SOLE | 2,944,201 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 5,356 | 1,174,500 | SH | SOLE | 1,174,500 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 20,156 | 7,635,000 | SH | SOLE | 7,635,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,881 | 205,500 | SH | SOLE | 205,500 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,005 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
NOVAVAX INC | COM | 670002104 | 138 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 4,242 | 337,500 | SH | SOLE | 337,500 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 2,523 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 518 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 9,545 | 381,500 | SH | SOLE | 381,500 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 6,023 | 815,000 | SH | SOLE | 815,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 5,613 | 552,500 | SH | SOLE | 552,500 | 0 | 0 |